All Journals > Clinical Infectious Diseases > 1 December 2007 > Evolution of the XDR‐F15/LAM4/KZN Strain

Article Tools

Search for Related Articles

Announcements

CID LISTED AMONG
“MOST INFLUENTIAL”

Clinical Infectious Diseases has been named as one of the "100 Most Influential Journals in Biology and Medicine" of the past 100 years by the Special Libraries Association. The list was compiled by the 680-plus members of SLA’s Biomedical and Life Sciences Division.

See the full list here.

Source: The DBIO 100, the 100 Most Influential Journals in Biology & Medicine over the last 100 Years

In the News

Featured in MSNBC
"Germs and flu are up; infection control is down" June 9, 2009
Trends in the Incidence of Methicillin‐Resistant Staphylococcus aureus Infection in Children’s Hospitals in the United States
Jeffrey S. Gerber, Susan E. Coffin, Sarah A. Smathers, and Theoklis E. Zaoutis
Just this week, researchers reported that the incidence of MRSA infections among children admitted to pediatric hospitals in the United States more than tripled between 2002 and 2007. Researchers at the Children’s Hospital of Philadelphia and the University of Pennsylvania found cases of MRSA jumped from 6.7 per 1,000 admissions in 2002 to 21.1 cases per 1,000 admissions in 2007, according to a study released online Monday in the journal Clinical Infectious Diseases.

Featured in Toronto Star
"Pigs, viruses and politics" May 2, 2009
Are Swine Workers in the United States at Increased Risk of Infection with Zoonotic Influenza Virus?
Kendall P. Myers, Christopher W. Olsen, Sharon F. Setterquist, Ana W. Capuano, Kelley J. Donham, Eileen L. Thacker, James A. Merchant, and Gregory C. Gray
Another study, this one published in the U.S. journal Clinical Infectious Diseases in 2006, found that workers in meat-processing plants have a greater likelihood of being infected by some version of the H1N1 flu virus than the general population (the odds of pig farmers getting the disease are significantly greater again).

Featured in Philadelphia Inquirer
"A shot in the arm for vaccines" April 19, 2009
Vaccines: Pneumococcal Vaccination of Elderly Adults: New Paradigms for Protection
Lisa A. Jackson and Edward N. Janoff
Every year, an estimated 915,000 people 65 and older get pneumonia, and 40 percent of them end up in hospitals, according to a 2004 paper in the journal Clinical Infectious Diseases. Pneumonia often kills older people, said Richard Stefanacci, a geriatrician at the University of the Sciences in Philadelphia.

1 December 2007

Volume 45, Number 11
Clinical Infectious Diseases 2007;45:1409–1414
© 2007 by the Infectious Diseases Society of America. All rights reserved.
1058-4838/2007/4511-0001$15.00
DOI: 10.1086/522987
CSE THEME ARTICLE MAJOR ARTICLE

Evolution of the Extensively Drug‐Resistant F15/LAM4/KZN Strain of Mycobacterium tuberculosis in KwaZulu‐Natal, South Africa

Manormoney Pillay and

A. Willem Sturm

Department of Medical Microbiology, Nelson R. Mandela School of Medicine, University of KwaZulu‐Natal, South Africa

Background.Although several hot spots of multidrug‐resistant tuberculosis have been identified on the African continent, extensive drug resistance (XDR) has not been reported until recently, when a large number of XDR cases were identified in KwaZulu‐Natal. The majority of the patients involved were infected with the same strain of Mycobacterium tuberculosis (F15/LAM4/KZN). We report this strain's development from multidrug resistance to XDR.

Methods.We searched databases for studies performed during the period 1994–2005 that involved the resistance patterns of isolates of M. tuberculosis with the F15/LAM4/KZN strain fingerprint.

Results.As early as 1994, the F15/LAM4/KZN strain was responsible for a number of cases of multidrug‐resistant tuberculosis, indicating the ability of the strain to cause cases of primary resistant tuberculosis. Some of the isolates were also resistant to streptomycin. From 1994 onwards, multidrug‐resistant isolates with resistance to additional drugs were found, and the first XDR isolate was discovered in 2001.

Conclusions.Drug resistance to as many as 7 drugs developed in a local strain of M. tuberculosis in slightly more than a decade. This coincided with the introduction of the directly observed therapy–based and directly observed therapy–plus–based tuberculosis‐control programs. It is postulated that the introduction of these programs in the absence of susceptibility testing or drug resistance surveillance has been instrumental in the development of XDR in this highly transmissible F15/LAM4/KZN strain. The expanding pool of human immunodeficiency virus–infected, tuberculosis‐susceptible individuals has likely contributed to this development.

Received 9 April 2007; accepted 6 July 2007; electronically published 22 October 2007.

  • (See the editorial commentary by Iseman on pages 1415–6)

Reprints or correspondence: Dr. A. Willem Sturm, Dept. of Medical Microbiology, Nelson R. Mandela School of Medicine, Private Bag 7, Congella, 4013, Durban, University of KwaZulu‐Natal, South Africa ().

CSE Global Theme Issue on Poverty and Human Development

Cited by

Stephen D Lawn, Gavin Churchyard. (2009) Epidemiology of HIV-associated tuberculosis. Current Opinion in HIV and AIDS 4:4, 325-333
Online publication date: 1-Aug-2009.
CrossRef
Sanjay Basu, Alison P. Galvani. (2009) The Evolution of Tuberculosis Virulence. Bulletin of Mathematical Biology 71:5, 1073-1088
Online publication date: 1-Aug-2009.
CrossRef
S. Basu, G. H. Friedland, J. Medlock, J. R. Andrews, N. S. Shah, N. R. Gandhi, A. Moll, P. Moodley, A. W. Sturm, A. P. Galvani. (2009) Averting epidemics of extensively drug-resistant tuberculosis. Proceedings of the National Academy of Sciences 106:18, 7672-7677
Online publication date: 5-Jun-2009.
CrossRef
Christopher Dye. (2009) Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis. Nature Reviews Microbiology 7:1, 81-87
Online publication date: 1-Feb-2009.
CrossRef
Neel R Gandhi, Anthony P Moll, Umesh Lalloo, Robert Pawinski, Kimberly Zeller, Pravi Moodley, Eugene Meyer, Gerald Friedland. (2009) Successful Integration of Tuberculosis and HIV Treatment in Rural South Africa: The Sizonqoba Study. JAIDS Journal of Acquired Immune Deficiency Syndromes 50:1, 37-43
Online publication date: 1-Feb-2009.
CrossRef
Edward D Chan, Michael D Iseman. (2009) Multidrug-resistant and extensively drug-resistant tuberculosis: a review. Current Opinion in Infectious Diseases 21:6, 587-595
Online publication date: 1-Jan-2009.
CrossRef
S. BASU, A. P. GALVANI. (2009) The transmission and control of XDR TB in South Africa: an operations research and mathematical modelling approach. Epidemiology and Infection 136:12, 1585
Online publication date: 1-Jan-2009.
CrossRef
Jerrold J. Ellner. (2009) The Emergence of Extensively Drug-Resistant Tuberculosis: A Global Health Crisis Requiring New Interventions: Part I: The Origins and Nature of the Problem. Clinical and Translational Science 1:3, 249-254
Online publication date: 1-Jan-2009.
CrossRef
Jason R. Andrews, Neel R. Gandhi, Prashini Moodley, N. Sarita Shah, Louise Bohlken, Anthony P. Moll, Manormoney Pillay, Gerald Friedland, and A. Willem Sturm on behalf of the Tugela Ferry Care and Research Collaboration. (2008) Exogenous Reinfection as a Cause of Multidrug‐Resistant and Extensively Drug‐Resistant Tuberculosis in Rural South Africa. The Journal of Infectious Diseases 198:11, 1582-1589
Online publication date: 1-Dec-2008.
Abstract-Full Text-PDF Version (252 kB)
Amita Jain, Pratima Dixit. (2008) Multidrug resistant to extensively drug resistant tuberculosis: What is next?. Journal of Biosciences 33:4, 605-616
Online publication date: 1-Dec-2008.
CrossRef
Ritu Banerjee, Gisela F Schecter, Jennifer Flood, Travis C Porco. (2008) Extensively drug-resistant tuberculosis: new strains, new challenges. Expert Review of Anti-infective Therapy 6:5, 713-724
Online publication date: 1-Nov-2008.
CrossRef
Yong Soo Kwon, Yee Hyung Kim, Gee Young Suh, Man Pyo Chung, Hojoong Kim, O Jung Kwon, Yong Soo Choi, Kwhanmien Kim, Jhingook Kim, Young Mog Shim, and Won‐Jung Koh. (2008) Treatment Outcomes for HIV‐Uninfected Patients with Multidrug‐Resistant and Extensively Drug‐Resistant Tuberculosis. Clinical Infectious Diseases 47:4, 496-502
Online publication date: 15-Aug-2008.
Abstract-Full Text-PDF Version (261 kB)
Ritu Banerjee, Jennifer Allen, Janice Westenhouse, Peter Oh, William Elms, Ed Desmond, Annette Nitta, Sarah Royce, and Jennifer Flood. (2008) Extensively Drug‐Resistant Tuberculosis in California, 1993–2006. Clinical Infectious Diseases 47:4, 450-457
Online publication date: 15-Aug-2008.
Abstract-Full Text-PDF Version (331 kB)
Amita Jain, Rajesh Mondal. (2008) Extensively drug-resistant tuberculosis: current challenges and threats. FEMS Immunology & Medical Microbiology 53:2, 145-150
Online publication date: 1-Aug-2008.
CrossRef
Chiang Chen-Yuan, Donald A Enarson, Paula I Fujiwara, Armand Van Deun, Lee Jen-Jyh. (2008) Strategies of extensively drug-resistant TB risk management for health workers and other care givers. Expert Review of Respiratory Medicine 2:1, 47-54
Online publication date: 1-Mar-2008.
CrossRef
Heidi Ledford. (2007) The evolution of a killer. Nature
Online publication date: 28-Dec-2007.
CrossRef
Michael D. Iseman
CSE Poverty and Human Development. (2007) Editorial Commentary: Extensively Drug‐Resistant Mycobacterium tuberculosis: Charles Darwin Would Understand. Clinical Infectious Diseases 45:11, 1415-1416
Online publication date: 1-Dec-2007.
Citation-Full Text-PDF Version (149 kB)
Back to Top
Close Popup